Clin Mol Hepatol.
2026 Jan;32(1):e10-e12. 10.3350/cmh.2025.0216.
Letter to the editor on “GULP1 as a novel diagnostic and predictive biomarker in hepatocellular carcinoma”
- Affiliations
-
- 1Department of Gastroenterology, Affiliated Hospital of Yunnan University, Yunnan, China
- 2Graduate School of Clinical Medicine, Dali University, Yunnan, China
- 3Department of Gastroenterology, The Third People’s Hospital of Yunnan Province, Yunnan, China
- KMID: 2575398
- DOI: http://doi.org/10.3350/cmh.2025.0216
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Correspondence to letter to the editor on “GULP1 as a novel diagnostic and predictive biomarker in hepatocellular carcinoma”
- GULP1, a multifaceted diagnostic biomarker and potential therapeutic target in hepatocellular carcinoma: Editorial on “GULP1 as a novel diagnostic and predictive biomarker in hepatocellular carcinoma”
- GULP1: New hope for hepatocellular carcinoma: Reply to correspondence on “GULP1 as a novel diagnostic and predictive biomarker in hepatocellular carcinoma”
- Unveiling GULP1 as a hepatocyte-specific role for recurrence: Editorial on “GULP1 as a novel diagnostic and predictive biomarker in hepatocellular carcinoma”
- Correspondence to editorial on “GULP1 as a novel diagnostic and predictive biomarker in hepatocellular carcinoma”
